These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 28260367
21. Initial exploration of oral pazopanib in healthy participants and patients with age-related macular degeneration. McLaughlin MM, Paglione MG, Slakter J, Tolentino M, Ye L, Xu CF, Suttle AB, Kim RY. JAMA Ophthalmol; 2013 Dec; 131(12):1595-601. PubMed ID: 24113783 [Abstract] [Full Text] [Related]
23. Complement factor H Y402H polymorphism and characteristics of exudative age-related macular degeneration lesions. Seitsonen S, Järvelä I, Meri S, Tommila P, Ranta P, Immonen I. Acta Ophthalmol; 2008 Jun; 86(4):390-4. PubMed ID: 17995985 [Abstract] [Full Text] [Related]
24. C-reactive protein and complement factor H polymorphism interaction in advanced exudative age-related macular degeneration. Soheilian R, Jabbarpour Bonyadi MH, Moein H, Babanejad M, Ramezani A, Yaseri M, Soheilian M. Int Ophthalmol; 2017 Oct; 37(5):1161-1168. PubMed ID: 27778189 [Abstract] [Full Text] [Related]
25. Y402H polymorphism in complement factor H and age-related macular degeneration in the Tunisian population. Habibi I, Sfar I, Kort F, Aounallah-Skhiri H, Chebil A, Chouchene I, Bouraoui R, Limaiem R, Largheche L, Jendoubi-Ayed S, Makhlouf M, Ben Abdallah T, Ayed K, El Matri L, Gorgi Y. Ophthalmic Res; 2013 Oct; 49(4):177-84. PubMed ID: 23306536 [Abstract] [Full Text] [Related]
26. Complement factor H variant Y402H and basal laminar deposits in exudative age-related macular degeneration. Lommatzsch A, Hermans P, Weber B, Pauleikhoff D. Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1713-6. PubMed ID: 17704937 [Abstract] [Full Text] [Related]
27. Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis. Jabbarpoor Bonyadi MH, Yaseri M, Bonyadi M, Soheilian M. Int Ophthalmol; 2017 Dec; 37(6):1397-1409. PubMed ID: 28005184 [Abstract] [Full Text] [Related]
28. CFH Y402H polymorphism and response to intravitreal ranibizumab in Brazilian patients with neovascular age-related macular degeneration. Veloso CE, Almeida LN, Nehemy MB. Rev Col Bras Cir; 2014 Dec; 41(6):386-92. PubMed ID: 25742403 [Abstract] [Full Text] [Related]
29. Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab. Lee AY, Raya AK, Kymes SM, Shiels A, Brantley MA. Br J Ophthalmol; 2009 May; 93(5):610-3. PubMed ID: 19091853 [Abstract] [Full Text] [Related]
30. Clinical study of the correlation between complement factor H polymorphism and age-related macular degeneration. Dong HT, Zhang JX, Li QM, Li FZ. Genet Mol Res; 2016 Sep 16; 15(3):. PubMed ID: 27706724 [Abstract] [Full Text] [Related]
31. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Thakkinstian A, Han P, McEvoy M, Smith W, Hoh J, Magnusson K, Zhang K, Attia J. Hum Mol Genet; 2006 Sep 15; 15(18):2784-90. PubMed ID: 16905558 [Abstract] [Full Text] [Related]
32. Association between CFH Y402H polymorphism and age related macular degeneration in North Indian cohort. Sharma NK, Gupta A, Prabhakar S, Singh R, Sharma SK, Chen W, Anand A. PLoS One; 2013 Sep 15; 8(7):e70193. PubMed ID: 23922956 [Abstract] [Full Text] [Related]
33. Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Lin JM, Wan L, Tsai YY, Lin HJ, Tsai Y, Lee CC, Tsai CH, Tseng SH, Tsai FJ. Am J Ophthalmol; 2008 Jun 15; 145(6):1045-1051. PubMed ID: 18378209 [Abstract] [Full Text] [Related]
34. Association between variant Y402H in age-related macular degeneration (AMD) susceptibility gene CFH and treatment response of AMD: a meta-analysis. Chen H, Yu KD, Xu GZ. PLoS One; 2012 Jun 15; 7(8):e42464. PubMed ID: 22905135 [Abstract] [Full Text] [Related]
35. Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration. Agosta E, Lazzeri S, Orlandi P, Figus M, Fioravanti A, Di Desidero T, Sartini MS, Nardi M, Danesi R, Bocci G. Pharmacogenomics; 2012 Jul 15; 13(9):1037-53. PubMed ID: 22838951 [Abstract] [Full Text] [Related]
36. Complement factor H Y402H polymorphism results in diminishing CD4+ T cells and increasing C-reactive protein in plasma. Nielsen MK, Subhi Y, Falk M, Singh A, Sørensen TL, Nissen MH, Faber C. Sci Rep; 2023 Nov 08; 13(1):19414. PubMed ID: 37940659 [Abstract] [Full Text] [Related]
37. Novel association of FCGR2A polymorphism with age-related macular degeneration (AMD) and development of a novel CFH real-time genotyping method. Velissari A, Skalidakis I, Oliveira SC, Koutsandrea C, Kitsos G, Petersen MB, Kroupis C. Clin Chem Lab Med; 2015 Sep 01; 53(10):1521-9. PubMed ID: 25811666 [Abstract] [Full Text] [Related]
38. Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism. Droz I, Mantel I, Ambresin A, Faouzi M, Schorderet DF, Munier FL. Br J Ophthalmol; 2008 Apr 01; 92(4):513-7. PubMed ID: 18211923 [Abstract] [Full Text] [Related]
39. Association of CFH Y402H polymorphism with both forms of advanced age-related macular degeneration in Turkish patients. Yücel D, Yılmaz M, Durukan AH, Özgül RK. Ophthalmic Genet; 2012 Sep 01; 33(3):144-9. PubMed ID: 22486323 [Abstract] [Full Text] [Related]
40. Age-related macular degeneration: a perspective on genetic studies. Patel N, Adewoyin T, Chong NV. Eye (Lond); 2008 Jun 01; 22(6):768-76. PubMed ID: 17491602 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]